XML 96 R85.htm IDEA: XBRL DOCUMENT v3.25.3
Debt Obligations - Life Sciences Narrative (Details) - USD ($)
 3 Months Ended 9 Months Ended
Aug. 04, 2025
Jan. 31, 2024
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Aug. 04, 2024
Jan. 30, 2024
Debt Instrument [Line Items]                    
Accrued interest and exit fees (current portion)     $ 60,200,000     $ 60,200,000   $ 61,000,000.0    
Current portion of debt obligations     $ 571,800,000     $ 571,800,000   162,200,000    
R2 Technologies | Lancer Promissory Note | Related Party | Life Sciences                    
Debt Instrument [Line Items]                    
Optional prepayment, number of days written notice 5 days                  
Interest rate 12.00%   12.00%     12.00%        
Face amount $ 43,500,000                  
Short-term debt     $ 46,500,000     $ 46,500,000   24,000,000    
Exit fees (non-current portion)               7,900,000    
Outstanding debt     $ 46,500,000     $ 46,500,000   $ 24,000,000    
Interest rate, effective percentage     17.00%     17.00%   57.80%    
Interest expense, debt     $ 3,100,000   $ 4,500,000 $ 12,800,000 $ 6,400,000      
Interest costs capitalized           3,800,000 $ 2,800,000      
Current portion of debt obligations     44,600,000     44,600,000   $ 31,900,000    
Unamortized discount     $ 1,900,000     $ 1,900,000        
R2 Technologies | Senior Notes, Due 2025, 20.00% | Related Party | Life Sciences                    
Debt Instrument [Line Items]                    
Interest rate   20.00%           20.00%   20.00%
Face amount $ 20,000,000 $ 20,000,000                
Short-term debt   17,400,000                
Accrued interest and exit fees (current portion)   $ 2,600,000             $ 7,000,000  
Exit fees (non-current portion)       $ 16,500,000         $ 16,500,000  
Extension fee percentage 5.00%                  
Debt instrument, extension fee $ 2,200,000                  
Exit fee percentage   10.50%   13.09%            
Exit fees   $ 2,200,000   $ 8,700,000            
Additional exit fee payable       1,000,000            
Increase in exit fee per month       $ 1,000,000            
Gains (losses) on restructuring of debt $ 0